.Amgen has discussed (PDF) the 1st stage 3 data on its $400 thousand eczema medication, linking the ...
.Biogen and UCB's depend improving in to phase 3 on the back of a broken research study seeks to hav...
.Italian biotech Aptadir Rehabs has launched along with the commitment that its own pipeline of prec...
.Wave Life Sciences has actually satisfied its target in a Duchenne muscular dystrophy (DMD) study, ...
.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma layer, occu...
.Achilles Rehabs has shreded its own strategy. The British biotech is knocking off on its clinical-p...
.Aligos Therapeutics is actually heralding a midstage win in metabolic-dysfunction associated steato...
.Basilea Pharmaceutica's work developing new antifungals has gotten a significant improvement coming...
.Having actually scooped up the united state legal rights to Capricor Rehabs' late-stage Duchenne mu...
.After pushing back the decision meeting for Applied Rehabs' metabolic condition drug govorestat, th...